182 related articles for article (PubMed ID: 29575270)
1. The immunomodulatory role of tumor-derived extracellular vesicles in colorectal cancer.
Manning S; Danielson KM
Immunol Cell Biol; 2018 Mar; ():. PubMed ID: 29575270
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic Tumor Cell-Derived Extracellular Vesicles Stimulate CD8 T Cell Response in Colorectal Cancer.
Gates TJ; Wangmo D; Zhao X; Subramanian S
bioRxiv; 2023 Apr; ():. PubMed ID: 37131597
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic tumor cell-derived extracellular vesicles stimulate CD8 T cell response in colorectal cancer.
Gates TJ; Wangmo D; Zhao X; Subramanian S
Mol Ther Oncolytics; 2023 Dec; 31():100727. PubMed ID: 37822487
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived extracellular vesicles in the colorectal cancer immune environment and immunotherapy.
Prakash A; Gates T; Zhao X; Wangmo D; Subramanian S
Pharmacol Ther; 2023 Jan; 241():108332. PubMed ID: 36526013
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Derived Extracellular Vesicles and the Immune System-Lessons From Immune-Competent Mouse-Tumor Models.
Droste M; Thakur BK; Eliceiri BP
Front Immunol; 2020; 11():606859. PubMed ID: 33391275
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Derived Extracellular Vesicles: Modulation of Cellular Functional Dynamics in Tumor Microenvironment and Its Clinical Implications.
Santos NL; Bustos SO; Bhatt D; Chammas R; Andrade LNS
Front Cell Dev Biol; 2021; 9():737449. PubMed ID: 34532325
[TBL] [Abstract][Full Text] [Related]
7. CD44 and Tumor-Derived Extracellular Vesicles (TEVs). Possible Gateway to Cancer Metastasis.
Szatanek R; Baj-Krzyworzeka M
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540535
[TBL] [Abstract][Full Text] [Related]
8. Tumor-derived extracellular vesicles in breast cancer: From bench to bedside.
Wang HX; Gires O
Cancer Lett; 2019 Sep; 460():54-64. PubMed ID: 31233837
[TBL] [Abstract][Full Text] [Related]
9. Molecular Determinants Involved in the Docking and Uptake of Tumor-Derived Extracellular Vesicles: Implications in Cancer.
Clares-Pedrero I; Rocha-Mulero A; Palma-Cobo M; Cardeñes B; Yáñez-Mó M; Cabañas C
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542421
[TBL] [Abstract][Full Text] [Related]
10. Circulating extracellular vesicles derived from tumor endothelial cells hijack the local and systemic anti-tumor immune response: Role of mTOR/G-CSF pathway.
Koni M; Lopatina T; Grange C; Sarcinella A; Cedrino M; Bruno S; Buffolo F; Femminò S; Camussi G; Brizzi MF
Pharmacol Res; 2023 Sep; 195():106871. PubMed ID: 37506784
[TBL] [Abstract][Full Text] [Related]
11. The capture of extracellular vesicles endogenously released by xenotransplanted tumours induces an inflammatory reaction in the premetastatic niche.
Blavier L; Nakata R; Neviani P; Sharma K; Shimada H; Benedicto A; Matei I; Lyden D; DeClerck YA
J Extracell Vesicles; 2023 May; 12(5):e12326. PubMed ID: 37194998
[TBL] [Abstract][Full Text] [Related]
12. Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity.
Han J; Kim S; Hwang YH; Kim SA; Lee Y; Kim J; Cho S; Woo J; Jeong C; Kwon M; Nam GH; Kim IS
Adv Sci (Weinh); 2024 Apr; ():e2308662. PubMed ID: 38666427
[TBL] [Abstract][Full Text] [Related]
13. Small Extracellular Vesicles: Key Forces Mediating the Development and Metastasis of Colorectal Cancer.
Zhang W; Hu X; Jiang Z
Cells; 2022 May; 11(11):. PubMed ID: 35681475
[TBL] [Abstract][Full Text] [Related]
14. Advances and challenges in clinical applications of tumor cell-derived extracellular vesicles.
Yu L; Zeng X; Hu X; Wen Q; Chen P
Colloids Surf B Biointerfaces; 2024 Feb; 234():113704. PubMed ID: 38113751
[TBL] [Abstract][Full Text] [Related]
15. The Role of Extracellular Vesicles as Modulators of the Tumor Microenvironment, Metastasis and Drug Resistance in Colorectal Cancer.
Siveen KS; Raza A; Ahmed EI; Khan AQ; Prabhu KS; Kuttikrishnan S; Mateo JM; Zayed H; Rasul K; Azizi F; Dermime S; Steinhoff M; Uddin S
Cancers (Basel); 2019 May; 11(6):. PubMed ID: 31146452
[TBL] [Abstract][Full Text] [Related]
16. CD44‑hyaluronan axis plays a role in the interactions between colon cancer‑derived extracellular vesicles and human monocytes.
Babula A; Gałuszka-Bulaga A; Węglarczyk K; Siedlar M; Baj-Krzyworzeka M
Oncol Lett; 2023 Sep; 26(3):413. PubMed ID: 37600336
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Derived Extracellular Vesicles in Cancer Immunoediting and Their Potential as Oncoimmunotherapeutics.
Najaflou M; Shahgolzari M; Khosroushahi AY; Fiering S
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612080
[TBL] [Abstract][Full Text] [Related]
18. Development of CD40L-modified tumor small extracellular vesicles for effective induction of antitumor immune response.
Liu W; Takahashi Y; Morishita M; Nishikawa M; Takakura Y
Nanomedicine (Lond); 2020 Jul; 15(17):1641-1652. PubMed ID: 32664826
[No Abstract] [Full Text] [Related]
19. Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer.
Plundrich D; Chikhladze S; Fichtner-Feigl S; Feuerstein R; Briquez PS
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269922
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids.
Subtil B; Iyer KK; Poel D; Bakkerus L; Gorris MAJ; Escalona JC; van den Dries K; Cambi A; Verheul HMW; de Vries IJM; Tauriello DVF
Front Immunol; 2023; 14():1105244. PubMed ID: 36761758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
